What matters most? For the 2012 Data Design Diabetes Innovation Challenge, we are inviting entrepreneurs, researchers, designers, and innovators from all over the US to show how their concepts provide real solutions for real people.
This year, the Innovation Challenge is focused on finding ideas that improve the quality, delivery, and cost of care. We have further shaped the Challenge by bringing in the wisdom of the crowd: we asked the public to voice their opinions about what matters most in the relationships, priorities, and experience of diabetes. The results of this crowdsourcing activity are woven throughout the criteria.
Submitted concepts for the 2012 Data Design Diabetes Innovation Challenge will be judged on the following attributes:
Specific :The Sanofi US Data Design Diabetes Innovation Challenge
What happens when you combine a wealth of insightful data, a heightened awareness of the human dimension of diabetes, and the effectiveness of well-designed health care products and services?
Sanofi US believes combining Data, Diabetes, and Design will impact our nation’s wellness significantly. The global health care provider is sponsoring an open innovation challenge combating the diabetes epidemic by integrating open data with a human-centered view into diabetes epidemic.
Building on the spirit of a code-a-thon, Sanofi US has created a challenge that casts the widest net for data-informed diabetes solutions, culls the best interventions, and incubates the strongest ideas. This challenge is structured to drive entrepreneurship and innovation. The best and most human-centered ideas will be mentored by industry leaders, and all intellectual property and equity will remain the property of its creators. Total awards top $200k, and invaluable support will be provided for game-changing solutions.
Through the best combination of Data sets, Design mentorship, and Diabetes insight, we will stem the tide of this epidemic together.
Official Rules
No Purchase Necessary
Sponsored by sanofi-aventis US, 55 Corporate Dr., Bridgewater, NJ 08807 (“Sponsor”). Void where prohibited. All entrants agree to be bound by these Official Rules.
Eligibility
The Sanofi US Data Design Diabetes Innovation Challenge competition (“Competition” or “Contest”) is open to all individuals over the age of 18 at the time of entry, internationally, including healthcare providers, patients, IT professionals, students and organizations interested in combining data and design to create a human-centered and data-inspired innovation around diabetes that is relevant to people with diabetes in the United States. Team submissions are accepted and strongly encouraged. Employees, officers and directors of sponsor and any of its affiliates, agents, parent or subsidiary companies and advertising and promotion agencies, and members of their immediate families (spouses, parents, children, and siblings and their spouses) and/or those living in the same household of each (whether or not related) are not eligible to participate. By participating, you agree to these Official Rules and the decisions of Sponsor, which are final and binding in all respects. Void outside of the 50 United States and the District of Columbia, and where prohibited, taxed or restricted by law. All federal, state and local laws and regulations apply.
At least one team member must be a legal U.S. Resident or Citizen throughout the duration of the Contest.
Timeframe
Submissions for the Competition can be made beginning 12:01am EST February 23, 2012, until March 23, 2012, at 11:59pm EST. Sponsor will announce five semi-finalists on www.datadesigndiabetes.com (the “Website”) on March 30, 2012, and each semi-finalist will receive an e-mail notification. The five semi-finalists will be provided mentorship and participate in a design boot camp during the month of April 2012. Semi-finalists will take part in a “Demo Day” on May 16, 2012 in the New York Metropolitan area, contingent upon schedules. Videos of the Demo Day will be streamed to the Website, and open voting will take place for one (1) week. Sponsor will announce two finalists on the Website by May 24, 2012 and the 2 finalists will be notified by May 23, 2012 via email. The finalists will conduct a community uptake exercise to evaluate the merit of their prototype in a real-world scenario during the month of June 2012. The winning innovation will be announced by July 16, 2012.
Entry Requirements
(A) To Enter: Access the Website and complete the information fields; specifically, your full name, e-mail address, website address, additional IDs, location, 2 intention questions, 2 team details questions, concept name, target audience, concept description, data set usage description, human-centeredness description, impact question, and visual media.
All entry information and submissions, including team and concept details, shall be collectively referred to herein as the “Submissions” or each as a “Submission.” Prior to uploading your Submission, you must also affirmatively confirm that you have read, understand and agree to these Official Rules by clicking on the check box on the Submission form.
(B) Submission: Each Submission must consist of one (1) textual submission and one (1) visual asset. Submit your own original Submission to the submission page on the Website. Text Submissions must be accompanied by some type of visual media describing the proposed concept: a diagram, screenshot, doodle, a wireframe, or similar schematic.
(C) Submission Parameters: Submissions (i) must be the 100% original and sole creation of the entrant, and all right, title and interest, including but not limited to the copyright in any Submission, must be owned solely by the submitting entrant, (ii) may not have been submitted in any other competition prior or subsequent to the date of entry into this Promotion, (iii) may not have been published anywhere prior to the date of entry into this Promotion, (iv) may not infringe upon any third party’s rights, including but not limited to copyright, patent or trademarks/tradenames/logos, or rights of privacy or publicity, or contain material that is or may be considered defamatory, slanderous or libelous, or portray or depict any person, product or entity in a false light, (v) must be truthful and accurate in all respects, (vi) may not violate any law, rule or regulation, (vii) may not contain any virus, bugs or other deleterious material, and (viii) may not contain or depict, for example but not limited to, profanity, defamatory statements, words or symbols widely considered offensive to individuals of any certain race, ethnicity, religious, sexual orientation or socioeconomic group, threats to any person, place, business, group or world peace; and each entrant warrants and represents that his/her Submission complies with all of those conditions. Submissions cannot contain, among other things, the trademark, tradename or logo of any third party or entity or product (including but not limited to the trademark, tradename or logo of any product competitive with any product of Sponsor, and including, but not limited to, on clothing), cannot contain, name, depict or describe any person (living, dead or fictional) other than the entrant and cannot contain any material that is protected by copyright. Any non-complying Submission with these Official Rules will be subject to disqualification. By entering, each Entrant grants permission for the use of his/her Submission, and his/her name, and likeness, to be posted on the Internet (including the Website) in connection with this Challenge, and the advertising, promotion, and publicity of the Challenge, and otherwise, as stated in these Official Rules (as solely determined by Sponsor); and each Entrant warrants and represents that he/she has all right and authority to grant such permission. Notwithstanding anything to the contrary, however, there is no obligation of the Sponsor or any other person or entity to post or make any use of the Submission of any particular Entrant, or of any Entrant’s information.
(D) Conditions of Submission: Only fully completed entry forms are eligible. Proof of submission will not be deemed to be proof of receipt by Sponsor. Notwithstanding anything to the contrary, Sponsor reserves the right to disqualify any Submission that Sponsor, in its sole opinion, deems inappropriate. Questions concerning the Challenge will not be acknowledged or responded to, but technical questions only, for example, that may involve the inability to access the Website, or the inability to attach a visual asset to the Submission, can be sent to info@datadesigndiabetes.com. Submissions that do not conform to these Official Rules or are submitted in any manner other than stated in these Official Rules will be disqualified.
(A) Judging Phase: As Submissions are received, all eligible Submissions will be judged by a panel of judges determined by Sponsor to have the required knowledge and experience to apply the judging criteria: a Sanofi senior executive, Government representative, public figure with diabetes, venture capitalist, innovation leader, healthcare innovation leader, leading health care provider. Judging will be based and scored on the following judging criteria and stated point availability for each criterion: (i) Ability to meet the unique needs of people living with diabetes in a way that is differentiated from other solutions in the marketplace (up to 40 points); (ii) Scalability of the concept so that it can meet the needs of a large population of people living with diabetes (up to 20 points); (iii) Ability to address better care at a lower cost through innovation (up to 20 points); (iv) Attentiveness to both functional and behavioral conditions within the concept (up to 20 points). Subject to verification and compliance with these Official Rules, the five (5) entrants with the highest scoring Submissions will be selected as semi-finalists, on or about March 30, 2012. Two (2) finalists will be announced by May 24, 2012, and the winner will be announced on July 16, 2012. The two (2) selected Finalists will be chosen based on the strength of the concept, efficacy of their prototype, ability to “pitch” the solution during Demo Day, and the response to the product or service provided by people living with diabetes during the final community uptake phase. The judges will consider each of these components and determine one (1) winner. The winning team and solution will be announced on July 16, 2012. The winner will receive $100,000 to develop the concept, and may be invited to attend a private event (at a time and location determined at Sponsor’s sole discretion), with the Sponsor and /or judges.
(B) Semi-finalist Phase: The selected semi-finalists will be notified via e-mail on March 30, 2012. When notification of the semi-finalists is completed, or as soon as is practical thereafter, the Submissions selected as semi-finalists will be listed on the Website for public viewing. THE JUDGING SCORES WILL NOT BE POSTED OR OTHERWISE AVAILABLE.
Attendance
Selected semi-finalists must be able to attend a design boot camp in San Francisco to be scheduled during the week of April 23, 2012. Selected semi-finalists must also be able to attend and present at Demo Day on May 16, 2012. If a semi-finalist is unable to attend, they will not be considered for the next round, and they forfeit their award monies. The Sponsor will provide a stipend to the semi-finalists to defray reasonable transportation and travel costs to the design boot camp and Demo Day.
(C) Finalist Phase: The selected semi-finalists will participate in the Demo Day on May 16, 2012. Two (2) finalists will be notified via e-mail by May 23, 2012. When notification of the finalists is completed, or as soon as is practical thereafter, the Submissions selected as Finalists will be listed on the Website for public viewing. THE JUDGING SCORES WILL NOT BE POSTED OR OTHERWISE AVAILABLE.
NO PURCHASE NECESSARY. NO WRITTEN RESPONSE NECESSARY. A PURCHASE OR PARTICULAR RESPONSE DOES NOT IMPROVE YOUR CHANCE OF WINNING. VOID WHERE PROHIBITED. ODDS OF WINNING DEPEND ON NUMBER OF ELIGIBLE ENTRIES RECEIVED AND DETERMINATION OF JUDGES.
Sanofi US reserves the right to suspend, postpone, cease, terminate or otherwise modify the Innovation Challenge at any time, without assigning any reason, at its sole option and discretion and Sanofi US shall have no liability, whatsoever, in any such event.
Any individual or team that submits an entry to the Innovation Challenge(“Entrant”) selected as a semi-finalist or finalist must comply with all terms and conditions set forth in these Official Rules, and winning is contingent upon fulfilling all requirements. Finalists will be selected by open vote and by an industry-leading panel of judges. The Innovation Challenge will occur under the guidance of Sanofi US. Entrants agree to be bound by these rules and the decision of the judges, whose decisions are final.
Potential semi-finalists will be notified by e-mail by March 30, 2012; potential finalists will be notified by e-mail by May 23, 2012. If a potential semi-finalist, finalist or winner cannot be contacted and does not reply with appropriate affidavit and contact information within three (3) days after the first attempt to contact such potential semi-finalist, finalist, or winner, an alternate entrant will be selected in his or her place based on score and judges’ discretion. Should a semi-finalist or finalist drop-out or determined ineligible, the judges may select an alternate based on scoring and at their discretion, to encourage diversity of projects.
Prizes
The following prizes will be awarded to 5 semi-finalists: (1) $20,000 for development of the concept prototype (2) Intensive mentorship from industry leaders (selected by Sanofi US based on type of concept) to hone the concept (3) Design boot camp. From these 5 semi-finalists, 2 finalists will be selected and receive: (1) $10,000 to create a community uptake exercise to evaluate the prototype in a real-world scenario with people living with diabetes. From the finalists, one winner will be selected to receive $100,000 for further development of the prototype. Odds of winning dependent upon number of entries submitted and strength of entry based on the judgment of the judges.
Total estimated retail value of all prizes is $220,000. There will be no substitutions for prizes. Prizes awarded are non-transferable and may not be exchanged or redeemed for cash, sold, or traded. Sponsor reserves the right to substitute a prize, in which case a prize of equal or greater value will be awarded.
Materials submitted may be published in the public domain, royalty-free, by the Challenge organizers, in conjunction with promotions of this competition. All efforts on the part of Sanofi US will be in good faith to maintain correct acknowledgment of the submitter. Sanofi US will not make the content of the submissions available to any outside party except the Panel of Judges of the contest. Please NOTE: entrants retain full intellectual property (“IP”) rights to their submitted concepts.
In the event of a dispute, entries made by Internet will be deemed made by the authorized account holder of the e-mail address submitted at the time of entry. The "authorized account holder" is deemed the natural person who is assigned to an e-mail address by an Internet access provider, service provider or other online organization that is responsible for assigning e-mail addresses for the domain associated with the submitted e-mail address. A potential winner may be requested to provide Sanofi US with proof that the potential winner is the authorized account holder of the e-mail address associated with the winning entry. If for any reason the Challenge is not capable of running as planned, including due to infection by computer virus, bugs, tampering, unauthorized intervention, fraud, technical failure, human error or any other causes beyond the control of Sanofi US that corrupt or affect the administration, security, fairness, integrity, or proper conduct of the Challenge, Sanofi US reserves the right in their sole discretion, to disqualify any individual who tampers with the entry process, and to cancel, terminate, modify or suspend the Challenge. Sanofi US assumes no responsibility for any error, omission, interruption, deletion, defect, delay in operation or transmission, communications line failure, theft or destruction or unauthorized access to, or alteration of, entries. Sanofi US is not responsible for any problems or technical malfunction of any, computer online systems, servers, or providers, computer equipment, software, failure of any e-mail or entry to be received by Sanofi US on account of technical problems or traffic congestion on the Internet or at any web site, any combination thereof, or otherwise, including any injury or damage to entrant's or any other person's computer related to or resulting from participation or downloading any materials in the Challenge. Sanofi US is not responsible for late, lost, illegible, incomplete, stolen, or misdirected entries. CAUTION: ANY ATTEMPT BY AN ENTRANT TO DELIBERATELY DAMAGE ANY WEB SITE OR UNDERMINE THE LEGITIMATE OPERATION OF THE Challenge MAY BE A VIOLATION OF CRIMINAL AND CIVIL LAWS AND SHOULD SUCH AN ATTEMPT BE MADE, SANOFI US RESERVES THE RIGHT TO SEEK DAMAGES FROM ANY SUCH PERSON TO THE FULLEST EXTENT PERMITTED BY LAW.
DISPUTE RESOLUTION/CHOICE OF LAW: Except where prohibited, each entrant agrees that: (1) any and all disputes, claims and causes of action arising out of or connected with this Promotion shall be resolved individually, without resort to any form of class action, and exclusively by the United States District Court or the appropriate State Court located in New York; (2) any and all claims, judgments and awards shall be limited to actual out-of-pocket costs incurred, including costs associated with participating in this Promotion, but in no event attorneys’ fees; and (3) under no circumstances will participant be permitted to obtain awards for, and participant hereby waives all rights to claim, indirect, punitive, incidental and consequential damages and any other damages, other than for actual out-of-pocket expenses, and any and all rights to have damages multiplied or otherwise increased.
All issues and questions concerning the construction, validity, interpretation and enforceability of these Official Rules, or the rights and obligations of the participant and Releases in connection with the Promotion, shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to any choice of law or conflict of law rules (whether of the State of New Jersey or any other jurisdiction), which would cause the application of the laws of any jurisdiction other than the State of New York.
SPONSOR: Sanofi-aventis US, 55 Corporate Drive, Bridgewater, NJ 08807
USE OF DATA: Sponsor will be collecting personal data about Entrants online, in accordance with its privacy policy. Please review the Sponsor’s privacy policy at
http://www.sanofi.us/l/us/en/layout.jsp?scat=643B1F48-7043-4A86-9DFA-A5C7038DC386.
By participating in the Challenge, Entrants hereby agree to Sponsor’s collection and usage of their personal information and acknowledge that they have read and accepted Sponsor’s privacy policy.
American Diabetes Association
The American Diabetes Association is leading the fight against the deadly consequences of diabetes and fighting for those affected by diabetes.
http://www.diabetes.org/
Center for Disease Control and Prevention
CDC's Division of Diabetes Translation translates diabetes research into daily practice to understand the impact of the disease, influence health outcomes, and improve access to quality health care.
http://www.cdc.gov/diabetes/
Health Data Community / healthdata.gov
A public resource designed to bring together high-value datasets, tools, and applications using data about health and health care.
http://www.healthdata.gov
Information on the Diabetes Belt
Geographic Distribution of Diagnosed Diabetes in the U.S. from American Journal of Preventive Medicine
(http://www.ajpmonline.org/article/S0749-3797%2811%2900035-3/abstract)
Scientific American: County-Level "Diabetes Belt" Carves a Swath through U.S. South
http://www.scientificamerican.com/article.cfm?id=diabetes-belt
Mayo Clinic
Health information on diabetes
http://www.mayoclinic.com/health/diabetes/DS01121
Startup America Partnership
Valuable resources and connections to help young companies grow.
http://www.startupamericapartnership.org/
World Health Organization
The mission of the WHO Diabetes Programme is to prevent diabetes whenever possible and, where not possible, to minimize complications and maximize quality of life.
http://www.who.int/diabetes/en/
January 26, 2012 – Competition announced and crowdsourcing begins.
February 12, 2012 – Last day to submit crowdsourcing form.
February 23, 2012 – Competition begins. Submissions accepted via entry form on the website.
March 23, 2012 – Last day to submit an entry.
March 30, 2012 – 5 semi-finalists announced and awarded $20,000.
April 2012 – 5 semi-finalists will be provided advice and mentorship from industry leaders in topics such as user experience, design, business modeling, and technology architecture. Semi-finalists will also participate in a design boot camp in San Francisco. Note: The function of this phase of the competition is to support the semi-finalists in creating a prototype of their concept. Travel is required to attend the design boot camp. The Sponsor will provide a stipend to the semi-finalists to defray reasonable travel costs.
May 16, 2012 – 5 semi-finalists will take part in a Demo Day to pitch their concepts in the New York Metropolitan area. Videos of the Demo Day will be streamed to the Website, and open voting will take place for one (1) week.
May 24, 2012 – Two finalists will be announced and awarded $10,000 to conduct a community uptake exercise. The community uptake exercise consists of engaging with a real community of people living with diabetes gather responses to their prototype. Finalists will determine the community uptake location and format with the Sponsors.
July 16, 2012 – Winner will be announced and awarded $100,000 to develop their prototype further.
All intellectual property and equity will remain the property of its creators throughout the entire competition. Please review the Rules and Terms & Conditions.
© 2012 sanofi-aventis U.S. LLC. A SANOFI COMPANY.
Privacy Policy |
Terms and Conditions
US.GLA.12.03.012